REGN vs SERV
Regeneron Pharmaceuticals Inc (REGN) versus Serve Robotics Inc. Common Stock (SERV) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Serve Robotics Inc. Common Stock (SERV) is a specialty industrial machinery company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SERV revenue for 2024-12-31 was $1.8M. Net income was -$39.2M. Revenue was up 773.3% from 2023-12-31 to 2024-12-31. SERV currently screens at market cap $614.4M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SERV currently screens at market cap $614.4M.
Not investment advice. Open the REGN and SERV stock pages for the full models.
Not investment advice.